Literature DB >> 3736898

The future role of neurosurgery in the care of cerebral tumors.

K Sano.   

Abstract

Diagnostic methods to discover a brain tumor and surgical techniques to remove it are steadily advancing. Most well-demarcated tumors can be removed by operation alone. Malignant, invasive tumors, however, will continue to offer a difficult and serious problem except when they are found while still very small in size, by elaborate diagnostic tools and except when they are conveniently located. For those tumors, surgery alone is not enough. Extermination of tumor cells by surgery, radiotherapy, chemotherapy, immunotherapy, etc., or combinations of these has achieved some results but with considerable limitations. We must search for the ways of peaceful coexistence with tumor cells, i.e., living with the tumor cells which are kept non-dividing and non-metastasizing by some means. Recent developments in oncology, such as discovery of c-onc genes, various growth factors, etc., give us some hope in the researches in this direction.

Entities:  

Mesh:

Year:  1986        PMID: 3736898     DOI: 10.1007/bf01743048

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  17 in total

1.  INTERNATIONAL SYMPOSIUM ON END RESULTS OF CANCER THERAPY. COMPUTATION OF SURVIVAL RATES.

Authors:  S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1964-10

2.  The distribution of nuclear DNA from human brain-tumor cells.

Authors:  T Hoshino; K Nomura; C B Wilson; K D Knebel; J W Gray
Journal:  J Neurosurg       Date:  1978-07       Impact factor: 5.115

Review 3.  Integrative treatment of gliomas.

Authors:  K Sano
Journal:  Clin Neurosurg       Date:  1983

4.  Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.

Authors:  G J Todaro; C Fryling; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 5.  Perspectives on clonogenic tumor cells, stem cells, and oncogenes.

Authors:  R N Buick; M N Pollak
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

Review 6.  Cellular oncogenes and multistep carcinogenesis.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

7.  Oncogenes.

Authors:  J M Bishop
Journal:  Sci Am       Date:  1982-03       Impact factor: 2.142

8.  Cell kinetic analyses of human malignant brain tumors (gliomas).

Authors:  T Hoshino; C B Wilson
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

9.  Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite.

Authors:  P H Reitsma; P G Rothberg; S M Astrin; J Trial; Z Bar-Shavit; A Hall; S L Teitelbaum; A J Kahn
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

10.  A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.

Authors:  T Hoshino
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

View more
  3 in total

1.  Immunotherapy of a murine T cell lymphoma localized to the brain.

Authors:  V K Ghant; N S Hiramoto; G Y Gillespie; D K Gauthier; R N Hiramoto
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

Review 2.  The rationale and requirements for the development of boron neutron capture therapy of brain tumors.

Authors:  A H Soloway; R F Barth; R A Gahbauer; T E Blue; J H Goodman
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study.

Authors:  K R von Wild; T H Knocke
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.